Marco Proietti
0000-0003-1452-2478
104 papers found
Refreshing results…
Optimizing Stroke and Bleeding Risk Assessment in Patients with Atrial Fibrillation: A Balance of Evidence, Practicality and Precision
Update on extended treatment for venous thromboembolism
Evolving concepts in atrial fibrillation epidemiology: Advancing knowledge about cardiovascular health in sub-Saharan Africa
Changes to oral anticoagulant therapy and risk of death over a 3-year follow-up of a contemporary cohort of European patients with atrial fibrillation final report of the EURObservational Research Programme on Atrial Fibrillation (EORP-AF) pilot general registry
Sex differences in stroke and major adverse clinical events in patients with atrial fibrillation: A systematic review and meta-analysis of 993,600 patients
Predicting Bleeding Events in Anticoagulated Patients With Atrial Fibrillation: A Comparison Between the HAS‐BLED and GARFIELD‐AF Bleeding Scores
Estimated Effectiveness and Safety of Nonvitamin K Antagonist Oral Anticoagulants Compared With Optimally Acenocoumarol Anticoagulated “Real-World” in Patients With Atrial Fibrillation
Improved Outcomes by Integrated Care of Anticoagulated Patients with Atrial Fibrillation Using the Simple ABC (Atrial Fibrillation Better Care) Pathway
Use of idarucizumab in reversing dabigatran anticoagulant effect: a critical appraisal
Heart rate variability in nephrotic syndrome: Role of sympathetic and parasympathetic system
Use of NOACs in the Peri-Operative Management of Patients with Atrial Fibrillation: To Stop, Bridge or Continue?
Use of oral anticoagulant drugs in older patients with atrial fibrillation in internal medicine wards
Autonomic dysfunction and cardiovascular risk in patients with atherosclerotic renal artery stenosis: A pilot study
Restarting oral anticoagulant therapy after major bleeding in atrial fibrillation: A systematic review and meta-analysis
Appropriateness of oral anticoagulant therapy prescription and its associated factors in hospitalized older people with atrial fibrillation
Association Between Peripheral Artery Disease and Incident Risk of Atrial Fibrillation: Strong Evidence Coming From Population‐Based Cohort Studies
The dangerous combination of atrial fibrillation and hypertension: An urgent need to handle complexity
Bleeding related to non-vitamin K antagonist oral anticoagulants in emergency department: A “Real-world” snapshot from Southern Italy. On behalf of MIRC-NOAC study group
Impact of quality of anticoagulation control on outcomes in patients with atrial fibrillation taking aspirin: An analysis from the SPORTIF trials
Real-World Use of Apixaban for Stroke Prevention in Atrial Fibrillation
Missing publications? Search for publications with a matching author name.